1-2 of 2
David A. Leinster
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt, Dyane Bailey, John Zielinski, Ameya Apte, Faith Musenge, Russell Karp, Shannon Burke, Fabien Garcon, Ankita Mishra, Sushma Gurumurthy, Amanda Watkins, Kristen Arnold, James Moynihan, Eleanor Clancy-Thompson, Kathy Mulgrew, Grace Adjei, Katharina Deschler, Darren Potz, Gordon Moody, David A. Leinster, Steve Novick, Michal Sulikowski, Chris Bagnall, Philip Martin, Jean-Martin Lapointe, Han Si, Chris Morehouse, Maja Sedic, Robert W. Wilkinson, Ronald Herbst, Joshua P. Frederick, Nadia Luheshi
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6284–6298.
https://doi.org/10.1158/1078-0432.CCR-20-0472
Published: 01 December 2020
View article titled, Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Open the PDF for Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist

Rebecca Leyland, Amanda Watkins, Kathy A. Mulgrew, Nicholas Holoweckyj, Lisa Bamber, Natalie J. Tigue, Emily Offer, John Andrews, Li Yan, Stefanie Mullins, Michael D. Oberst, Jane Coates Ulrichsen, David A. Leinster, Kelly McGlinchey, Lesley Young, Michelle Morrow, Scott A. Hammond, Philip Mallinder, Athula Herath, Ching Ching Leow, Robert W. Wilkinson, Ross Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (13): 3416–3427.
https://doi.org/10.1158/1078-0432.CCR-16-2000
Published: 02 July 2017
View article titled, A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist
Open the PDF for A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist in another window
Includes: Supplementary data